Burlington Stores Inc
Change company Symbol lookup
Select an option...
BURL Burlington Stores Inc
TNEN True North Energy Corp
H Hyatt Hotels Corp
ACEL Accel Entertainment Inc
USLM United States Lime & Minerals Inc
BWEN Broadwind Inc
EQIX Equinix Inc
TXMD TherapeuticsMD Inc
ORC Orchid Island Capital Inc
GBX Greenbrier Companies Inc
Go

Consumer Discretionary : Specialty Retail | Mid Cap Blend
Company profile

Burlington Stores, Inc. is a retailer of branded apparel. The Company operates approximately 866 retail stores in approximately 45 states and Puerto Rico. It sells in-season, fashion-focused merchandise, including women’s ready-to-wear apparel, menswear, youth apparel, baby, beauty, footwear, accessories, home, toys, gifts and coats. The Company operates five distribution centers. Its two east coast distribution centers are located in Edgewater Park, New Jersey and Burlington, New Jersey and three west coast distribution centers are located in San Bernardino, California, Redlands, California, and Riverside, California. It also operates warehousing facilities to support its distribution centers. The Company uses a mix of broad-based and targeted marketing strategies. Its broad-based strategies include national and local television and radio. Its digital and streaming audio strategies include personalized and targeted messaging.

Postmarket

Last Trade
Delayed
$0.00
0.00 (0.00%)
Bid
--
Ask
--
B/A Size
--

Market Hours

Closing Price
$156.99
Day's Change
2.99 (1.94%)
Bid
--
Ask
--
B/A Size
--
Day's High
160.24
Day's Low
156.78
Volume
(Light)
Volume:
664,945

10-day average volume:
917,487
664,945

Karuna Therapeutics to Host Virtual Event Highlighting Clinical Program for Psychosis in Alzheimer's Disease

6:30 am ET May 18, 2022 (BusinessWire) Print

Karuna Therapeutics, Inc. (NASDAQ: KRTX), a clinical-stage biopharmaceutical company driven to create and deliver transformative medicines for people living with psychiatric and neurological conditions, today announced that it will host a virtual event on Wednesday, May 25, 2022, at 8:00 a.m. ET. The one-hour webcast event will highlight progress across the ongoing and planned clinical programs of KarXT, with a primary focus on the planned Phase 3 program evaluating KarXT for the treatment of psychosis in Alzheimer's disease.

The event will feature presentations from members of Karuna's leadership team. To register for the event, please click here.

The webcast of the event will be available on the Investor Relations page of Karuna's website at investors.karunatx.com.

About Karuna Therapeutics

Karuna Therapeutics is a clinical-stage biopharmaceutical company driven to create and deliver transformative medicines for people living with psychiatric and neurological conditions. At Karuna, we understand there is a need for differentiated and more effective treatments that can help patients navigate the challenges presented by these severe and disabling disorders. Utilizing our extensive knowledge of neuroscience, we are harnessing the untapped potential of the brain in pursuit of novel pathways to develop medicines that make meaningful differences in peoples' lives. For more information, please visit www.karunatx.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20220518005282/en/

SOURCE: Karuna Therapeutics, Inc.

Investor Contact: 
Alexis Smith
518-338-8990
asmith@karunatx.com

Media Contact: 
Lauren Sneider
917-886-0247
lsneider@karunatx.com
comtex tracking

COMTEX_407381989/1006/2022-05-18T06:30:00

Earnings Calendar and Events Data provided by |Terms of Use| © 2022 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2022. All rights reserved.